News Adial Pharmaceuticals, Inc.

Equities

ADIL

US00688A2050

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
1.73 ^USD	+1.17%		-20.28%	-6.99%

Apr. 22	Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder	MT
Apr. 12	Top Premarket Decliners	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder	Apr. 22	MT
Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office	Apr. 22	AQ
Top Premarket Decliners	Apr. 12	MT
Top Midday Gainers	Apr. 10	MT
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder	Apr. 10	AQ
Adial Pharmaceuticals, Inc Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder	Apr. 10	CI
Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update	Apr. 02	AQ
Adial Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Adial Pharmaceuticals, Inc. announced that it has received $0.2875 million in funding	Mar. 13	CI
Adial Pharmaceuticals, Inc. announced that it expects to receive $0.2875 million in funding	Mar. 05	CI
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds	Mar. 04	AQ
Top Premarket Decliners	Mar. 04	MT
Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds	Mar. 01	AQ
Investors Await Key Economic Data, Markets Remain Flat Ahead of Opening Bell	Mar. 01	MT
US Futures Remain Flat as Investors Await Raft of Economic Data	Mar. 01	MT
Top Midday Gainers	Feb. 28	MT
Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office	Feb. 28	AQ
Adial Pharmaceuticals Secures US Patent Allowance for AD04, Genetic Diagnostic Combination	Feb. 13	MT
Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office	Feb. 13	AQ
Adial Pharmaceuticals Receives New Patent Notice of Allowance from the United States Patent and Trademark Office	Feb. 13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Adial Pharmaceuticals, Inc.

Equities

ADIL

US00688A2050

Summary

Filters